Novel mutation c.1224_1225insGTCC (p.Cys409Valfs*41) of MEN1 gene in a
multiple endocrine neoplasia type 1 case with insulinoma and primary
hyperparathyroidism: first report of a Costa Rican case
Abstract
Abstract Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal
dominant disorder characterized by a predisposition for tumors in the
parathyroid gland, anterior hypophysis and pancreatic islet cells. Here
we describe the first Costa Rican MEN1 case with a novel MEN1 mutation
in a 37-year-old male with history of nephrolithiasis and recurrent
hypoglycemic episodes. Initial laboratories revealed hypoglycemia and
primary hyperparathyroidism. A fasting test was positive at three hours
demonstrating hyperinsulinemic hypoglycemia. An abdominal CT SCAN showed
one mass in the pancreatic tail and bilateral nephrolithiasis. Direct
sequence analysis of MEN1 gene revealed heterozygosity for a novel
pathogenic insertion c.1224_1225insGTCC (p.Cys409Valfs*41). Early
genetic diagnosis of MEN1 could identify individuals in a presymptomatic
stage of the disease which could introduce them in periodic surveillance
programs for early identification and treatment of associated tumors.
Key words Multiple endocrine neoplasia, primary hyperparathyroidism,
insulinoma, hypoglycemia, nephrolithiasis